0001969223-26-000771.txt : 20260708 0001969223-26-000771.hdr.sgml : 20260708 20260708160512 ACCESSION NUMBER: 0001969223-26-000771 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20260708 DATE AS OF CHANGE: 20260708 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Bicara Therapeutics Inc. CENTRAL INDEX KEY: 0002023658 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-42271 FILM NUMBER: 261162440 BUSINESS ADDRESS: STREET 1: 116 HUNTINGTON AVENUE SUITE 703 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-468-4219 MAIL ADDRESS: STREET 1: 116 HUNTINGTON AVENUE SUITE 703 CITY: BOSTON STATE: MA ZIP: 02116 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Hyep Ivan CENTRAL INDEX KEY: 0002034668 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: BICARA THERAPEUTICS INC. STREET 2: 116 HUNTINGTON AVENUE, SUITE 703 CITY: BOSTON STATE: MA ZIP: 02116 144 1 primary_doc.xml 144 0002034668 XXXXXXXX LIVE 0002023658 Bicara Therapeutics Inc. 001-42271 116 HUNTINGTON AVENUE SUITE 703 BOSTON MA 02116 617-468-4219 Hyep Ivan Officer Common UBS Financial Services, Inc.

11 Madison Ave 4th Floor New York NY 10010

28000 847000.00 65703866 07/08/2026 NASDAQ Common 07/08/2026 Exercise of stock options Issuer N 12500 07/08/2026 Cash Common 05/08/2024 NQ Exercise Issuer N 15500 05/08/2024 NA N Ivan Hyep

116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116

Common 04/21/2026 9200 211613.80 Ivan Hyep

116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116

Common 05/21/2026 9200 187883.32 07/08/2026 03/31/2026 /s/ UBS Financial Services Inc., as attorney-in-fact for Ivan Hyep